Navigation Links
Harvard scientists visualize new treatments for retinal blindness
Date:3/26/2014

A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies). Specifically, scientists have discovered that the body's innate immune system does more than help ward off external pathogens. It also helps remove sight-robbing abnormal blood vessels, while leaving healthy cells and tissue intact. This discovery is significant as the retina is part of the central nervous system and its cells cannot be replaced once lost. Identifying ways to leverage the innate immune system to "clean out" abnormal blood vessels in the retina may lead to treatments that could prevent or delay blindness, or restore sight.

"Our findings begin to identify a new role of the innate immune system by which endogenous mediators selectively target the pathologic retinal vasculature for removal," said Kip M. Connor, Ph.D., a researcher involved in the work from the Department of Ophthalmology at the Harvard Medical School and Massachusetts Eye and Ear Infirmary Angiogenesis Laboratory in Boston, MA. "It is our hope that future studies will allow us to develop specific therapeutics that harnesses this knowledge resulting in a greater visual outcome and quality of life for patients suffering from diabetic retinopathy or retinopathy of prematurity."

To make this discovery, Connor and colleagues compared two groups of mice, a genetically modified group which lacked activity in the innate immune complement system, and a normal group with a fully functional innate immune system. Researchers placed both groups in an environment that induced irregular blood vessel growth in the eye, mimicking what happens in many human ocular diseases. The mice that were lacking a functional innate immune system developed significantly more irregular blood vessels than the normal mice, indicating that the complement system is a major regulator of abnormal blood vessel growth within the eye. Importantly, in the normal mice, scientists were able to visualize the immune system targeting and killing only the irregular blood vessels while leaving healthy cells unharmed.

"Knowing how the complement system works to keep our retinas clean is an important first-step toward new treatments that could mimic this activity," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "It's a new understanding of how proliferative retinopathies rob us of sight, and promises to let us see the path ahead clearly."


'/>"/>
Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. Harvard professor wins Nobel Prize of water
2. Harvard scientists find cell fate switch that decides liver, or pancreas?
3. Harvard scientists control cells following transplantation, from the inside out
4. Harvard study shows sprawl threatens water quality, climate protection, and land conservation gains
5. Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors
6. "GenoVive is changing the face of personalized health by continuing research efforts with Harvard."
7. Harvard Stem Cell researchers create cells that line blood vessels
8. Harvard and USC scientists show how DHA resolves inflammation
9. Harvards Wyss Institute and Sony DADC announce collaboration on Organs-on-Chips
10. Renewed Harvard-BASF initiative to advance functional materials
11. Got to go? Harvard scientists figure out how you know
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/25/2016)... Pa. , Jan. 25, 2016   Unisys Corporation ... system at John F. Kennedy (JFK) International Airport, New ... Protection (CBP) identify imposters attempting to enter the ... not belong to them. pilot testing of the ... initially at three terminals at JFK during January 2016. --> ...
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today provided an update on the Company,s cases ... Texas and announcing that those ... Re-examination ("IPR") proceedings that VTech and Uniden filed ... on only certain claims of two of the patents ...
(Date:2/3/2016)... 2016   ViaCyte, Inc ., a leading, ... stem cell-derived islet replacement therapy for the treatment ... announced that ViaCyte and Janssen Biotech, Inc., one ... Johnson, have agreed to consolidate the assets of ... provides ViaCyte with an exclusive license to all ...
(Date:2/3/2016)... , Feb. 3, 2016 New ... more than $1 million for researchers in ... on health-related research that demonstrates exciting potential.   ... of funding for the New Jersey Health Foundation Research ... members at these educational institutions— Princeton University, Rutgers ...
(Date:2/3/2016)... Mass. , Feb. 3, 2016  Silk Therapeutics, Inc., ... financing round. Silk Therapeutics has now raised a total of ... made by the company. The Series A2 round was led ... Massachusetts , with participation from new investors Lear Corporation ... Sheri and Roy P. Disney ; Richard Sackler , ...
Breaking Biology Technology: